CHINA
N27
Manufacturer/Innovator
Advanced Intermediates, Alimentary Tract and Metabolism, Antiinfectives for Systemic use, Cardiovascular System, Nervous System, Respiratory System, API Contract Manufacturing
Heryi is affiliated to 4 production bases and 2 R&D centers, with a total of over 500 employees.The production bases include Anhui Heryi Pharmaceutical Co., Ltd, Anhui Shiuyat Pharmaceutical Co., Ltd. and Liaoning Hersin Pharmaceutical Co., Ltd., Heryi-Dasan Pharmaceutical Co.,Ltd. The R&D centers include Heryi R&D center and Hangzhou Xiaobei Pharma Co., Ltd.
Heryi pharma has obtained GMP certificate (Ganciclovir) in 2018; wholly-owned subsidiary Shiuyat pharma has passed API register (Azintamide) and GMP compliance check in 2023. Both Heryi pharma and Shiuyat pharma have obtained the Accreditation certificate of foreign drug manufacturer.